Clinical Trial Update: Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients [Phase 1]

View source ↗

Summary

Phase 1 trial update of BAT8010 for injection in advanced malignant solid tumors assessing safety, tolerability, and pharmacokinetics; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• BAT8010

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Advanced or Metastatic Solid Tumors | Phase 1 | Status: COMPLETED